Terms: = Uterine cancer AND BTG1, P62324, 694, ENSG00000133639 AND Diagnosis
11 results:
1. Diagnostic Accuracy of Ultrasound in the diagnosis of uterine Leiomyomas and Sarcomas.
Raffone A; Raimondo D; Neola D; Travaglino A; Raspollini A; Giorgi M; Santoro A; De Meis L; Zannoni GF; Seracchioli R; Casadio P; Guida M
J Minim Invasive Gynecol; 2024 Jan; 31(1):28-36.e1. PubMed ID: 37778636
[TBL] [Abstract] [Full Text] [Related]
2. Unsuspected placenta accreta spectrum at vaginal delivery: assessment of incidence, characteristics, and maternal morbidity.
Rau AR; Youssefzadeh AC; Matsuzaki S; Mandelbaum RS; Ouzounian JG; Matsuo K
Am J Obstet Gynecol MFM; 2023 May; 5(5):100805. PubMed ID: 36774226
[TBL] [Abstract] [Full Text] [Related]
3. Non-aspirin NSAID use and mortality of endometrial cancer. A nationwide cohort study.
Sperling CD; Verdoodt F; Aalborg GL; Dehlendorff C; Friis S; Kjaer SK
Cancer Causes Control; 2021 May; 32(5):515-523. PubMed ID: 33620641
[TBL] [Abstract] [Full Text] [Related]
4. Effect of Menopausal Status on the diagnosis of Endometrial Polyp.
Namazov A; Gemer O; Bart O; Cohen O; Vaisbuch E; Kapustian V; Ben-Arie A
J Obstet Gynaecol Can; 2019 Jul; 41(7):926-929. PubMed ID: 30638834
[TBL] [Abstract] [Full Text] [Related]
5. Loss of PTEN expression as diagnostic marker of endometrial precancer: A systematic review and meta-analysis.
Raffone A; Travaglino A; Saccone G; Campanino MR; Mollo A; De Placido G; Insabato L; Zullo F
Acta Obstet Gynecol Scand; 2019 Mar; 98(3):275-286. PubMed ID: 30511743
[TBL] [Abstract] [Full Text] [Related]
6. [The prophylactic operational model integrated with occupational healthcare - Prophylactic of some types of cancers among women].
Wiszniewska M; Magnuska J; Lipińska-Ojrzanowska A; Pepłońska B; Hanke W; Kalinka J; Skręt-Magierło J; Zadrożny M; Walusiak-Skorupa J
Med Pr; 2018 Aug; 69(4):439-455. PubMed ID: 30038434
[TBL] [Abstract] [Full Text] [Related]
7. Statin use and mortality among endometrial cancer patients: a Danish nationwide cohort study.
Sperling CD; Verdoodt F; Kjaer Hansen M; Dehlendorff C; Friis S; Kjaer SK
Int J Cancer; 2018 Dec; 143(11):2668-2676. PubMed ID: 29923185
[TBL] [Abstract] [Full Text] [Related]
8. Direct costs of cervical cancer management in Morocco.
Berraho M; Najdi A; Mathoulin-Pelissier S; Salamon R; Nejjari C
Asian Pac J Cancer Prev; 2012; 13(7):3159-63. PubMed ID: 22994727
[TBL] [Abstract] [Full Text] [Related]
9. Impact of payer status on treatment of cervical cancer at a tertiary referral center.
Levinson KL; Bristow RE; Donohue PK; Kanarek NF; Trimble CL
Gynecol Oncol; 2011 Aug; 122(2):324-7. PubMed ID: 21620446
[TBL] [Abstract] [Full Text] [Related]
10. Rapid prescreening is as effective at reducing screening error as postscreening with the FocalPoint automated screening device.
Wilgenbusch H; Mueller G; Neal M; Renshaw AA
Diagn Cytopathol; 2011 Nov; 39(11):818-21. PubMed ID: 20949451
[TBL] [Abstract] [Full Text] [Related]
11. Risk of CIN2 in women with a pap test without endocervical cells vs. those with a negative pap test with endocervical cells: a cohort study with 4.5 years of follow-up.
Giorgi Rossi P; Baiocchi D; Ciatto S;
Acta Cytol; 2010; 54(3):265-71. PubMed ID: 20518409
[TBL] [Abstract] [Full Text] [Related]
